Michael Halpin
Chief Operating Officer en VERICEL CORPORATION .
Fortuna: 49 367 $ al 31/03/2024
Cargos activos de Michael Halpin
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| VERICEL CORPORATION | Chief Operating Officer | 15/06/2019 | - |
| General Counsel | 10/04/2017 | 15/06/2019 |
Historial de carrera de Michael Halpin
Antiguos cargos conocidos de Michael Halpin.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | General Counsel | 01/02/2002 | - |
| Corporate Officer/Principal | - | 01/04/2017 | |
| Sanofi Corp. | Corporate Officer/Principal | - | - |
Formación de Michael Halpin.
| University of Virginia | Graduate Degree |
Estadísticas
Internacional
| Estados Unidos | 5 |
Operativa
| General Counsel | 2 |
| Corporate Officer/Principal | 2 |
| Chief Operating Officer | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| VERICEL CORPORATION | Health Technology |
| Empresas privadas | 2 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
| Sanofi Corp. |
- Bolsa de valores
- Insiders
- Michael Halpin
- Experiencia
